This test is most useful if any of these apply to you.
MCHC (mean corpuscular hemoglobin concentration) is one of the numbers on a standard complete blood count, and most people skip it. That can be a mistake when it runs low. A low value means the red cells in that sample are underfilled with hemoglobin, usually because iron delivery or red-cell building has been off long enough to show up on the count.
Across large studies, a low reading has tracked with worse outcomes in people with heart, lung, kidney, and cancer conditions. It will not diagnose a disease on its own. But it is a cheap clue, already in your results, that something about your red cells is off.
MCHC is a calculated index from a whole-blood CBC, usually collected by a blood draw. It is worked out from hemoglobin and hematocrit: how much hemoglobin is packed into a given volume of red cells. Hemoglobin is the protein in red cells that carries oxygen. Picture each red cell as a container. MCHC tells you, on average, how full of hemoglobin those containers are.
A low value means the cells are underfilled. The lab word is hypochromia. These cells look paler because they are poor in hemoglobin. Because of that, MCHC mostly reflects your iron status and how well your body is building red cells, rather than the health of any single organ.
The most common reason MCHC drops is iron deficiency. Without enough iron, the body builds pale, hemoglobin-poor cells, and MCHC is one of the readings that reflects it. But it is a blunt, lagging index. It often stays normal in early iron deficiency and only falls once the deficiency is well established, so a normal MCHC does not rule out an iron problem.
Pregnancy makes this limitation clear. One large pregnancy study did not use MCHC as the main screen, but it tested the same idea: relying on CBC red-cell clues can miss iron deficiency. In more than 20,000 pregnancies, over half the women with documented iron deficiency were neither anemic nor small-celled at diagnosis, and hemoglobin and cell size each caught only about 30 out of 100 cases in the first trimester. If you want to catch iron trouble early, ferritin, a direct measure of iron stores, is far more sensitive than any red cell index.
In a study of 21,203 US adults, death risk fell as MCHC rose up to the mid-30s g/dL and then leveled off. The inflection point was about 34.35 g/dL in that model. This is not a target. It is a population pattern. Low is the risky end of the range, and unusually high values carried no extra risk in the general population. The same low-is-worse pattern shows up again and again in sicker groups.
| Who Was Studied | What Was Compared | What They Found |
|---|---|---|
| 21,203 US adults | Lower versus higher MCHC | Death risk from any cause was higher at lower values and flattened in that model once MCHC reached the mid-30s g/dL |
| 111,817 intensive care patients with acute kidney injury | Highest versus lowest quarter of MCHC | The highest group was about a third less likely to die in hospital |
| 20,055 intensive care patients with cancer | Highest versus lowest quarter of MCHC | The highest group was nearly half as likely to die within 30 and 90 days |
Sources: Li et al. 2023 (PLOS ONE); Chen et al. 2025 (European Journal of Medical Research); Zhang et al. 2026 (Cureus).
What this means for you: a low MCHC is not itself dangerous, and these are associations, not proof that the number causes anything. Treat it as a marker that travels with sicker physiology. When it is low, it is a prompt to look at your iron, inflammation, kidney function, and the rest of the count rather than a verdict in its own right.
In heart failure where the heart pumps normally but fills poorly, a low MCHC in the study's hypochromia group was linked to roughly 56% higher risk of the main combined outcome, but only in people who also had reduced kidney function. In nonanemic chronic heart failure, people in the lowest quarter of MCHC had about twice the death risk before full adjustment, and the signal remained after adjustment. A value that stayed low on repeat testing marked higher risk than a single dip.
In people with high blood pressure, an MCHC at or below about 33 g/dL was tied to roughly 26% higher all-cause death and 42% higher cardiovascular death. Lower MCHC also independently predicted death at 30 days, 1 year, and 3 years after an acute blood clot in the lungs, and predicted worse survival after a heart attack in intensive care. One exception: in acute coronary syndrome, MCHC did not predict later cardiac events, while cell size and hemoglobin-per-cell did.
The strongest data come from very large intensive care databases. In more than 111,000 patients with acute kidney injury and in more than 20,000 patients with cancer, higher MCHC on admission went with lower death rates. In chronic obstructive pulmonary disease (COPD), a low MCHC predicted 30-day death during a flare in one study and predicted future flares in stable disease in another, though a third study found it was not an independent predictor of death after full adjustment.
In pneumoconiosis, a lung disease from inhaled dust, lower MCHC tracked with more advanced disease. The pattern is consistent enough to be useful: when MCHC is low in someone already unwell, the illness often tends to be more serious.
A genuinely high MCHC is uncommon, and it points in a different direction than a low one. In hepatorenal syndrome, a serious complication of liver failure, patients in the highest quarter of MCHC had about 77% higher risk of a worse outcome. True elevations also show up in specific inherited red cell disorders. Hemoglobin C disease and hemoglobin SC disease can raise MCHC because red cells become denser. Elevated MCHC has also been studied as a marker of high-altitude pulmonary edema risk. One small pilot study linked higher values to Parkinson's disease, though that finding is preliminary.
So this isn't a simple good-number, bad-number marker. Low MCHC usually means hemoglobin-poor cells and often travels with worse illness. A genuinely high value means the cells are unusually dense or the sample is misleading. The direction matters more than the flag.
Before you take a high MCHC seriously, know that a markedly high value is more often a measurement problem than real biology. A few things fool the analyzer:
Because of this, most labs automatically flag a high MCHC for human review, and the usual next step is to check or redraw the sample rather than act on it. A high reading with no explanation is a signal to repeat the test, not to start a workup.
MCHC is most useful inside a hematology workup. In hereditary spherocytosis, an inherited condition with small, dense red cells, MCHC alone separated cases from non-cases well. In that study, MCHC's group-separation score was 0.92. A score of 1.0 is perfect, and 0.5 is a coin flip. For telling iron deficiency apart from thalassemia trait, formulas built around MCHC reach scores around 0.93, and machine-learning models that lean on MCHC can reach near 0.99 in external validation. For some forms of thalassemia, though, cell size and hemoglobin-per-cell beat MCHC on its own.
As a standalone screen it is only fair. A measure derived from MCHC caught about 61 out of 100 iron-deficiency cases and cleared about 67 out of 100 non-cases, at no added cost on a routine count. In Parkinson's disease, adolescent iron deficiency, and advanced pneumoconiosis, standalone MCHC scored around 0.7, which is fair, not strong. MCHC pulls its weight as part of a panel. Read alone, it is weak.
MCHC is one of the most stable indices on the count, and that cuts both ways. A single high value is often an artifact and should be repeated before you do anything with it. A low value is more trustworthy but moves slowly, because red cells live about four months, so any index that reflects them lags behind changes in your body.
If you're correcting iron deficiency, MCHC should be judged with ferritin, transferrin saturation, hemoglobin, MCV, and RDW. A value that stays low across repeat tests carries more weight than one reading, as the heart failure data showed. The trend beats the snapshot.
Evidence-backed interventions that affect your MCHC level
MCHC is best interpreted alongside these tests.
MCHC is included in these pre-built panels.